Amara Therapeutics - Accessible & Effective Treatments for Pelvic Floor ConditionsAmara Therapeutics - Accessible & Effective Treatments for Pelvic Floor Conditions
  • Home
  • About
  • News
  • Pipeline
    • Overactive Bladder
    • Stress Urinary Incontinence
    • Pelvic Organ Prolapse
    • Interstitial Cystitis
    • Sexual Dysfunction
  • Careers
  • Contact
Amara Therapeutics DTIF Funding Success

Amara Therapeutics DTIF Funding Success

The Disruptive Technologies Innovation Fund, a major driver of Impact 2030 research and innovation strategy, has awarded Amara Therapeutics funding for RiSolve - a safe and effective personalised therapy that will disrupt the overactive bladder treatment market using an innovative artificial intelligence-based digital platform.

Read the Departmental Press Release

Read more on Silicon Republic

Recent News

  • Making it Work: Avoiding delicate situations with the aid of a digital platform 07 April 2022
  • Amara features in Enterprise Ireland Big Ideas Event 22 September 2022
  • Cookie Policy 22 November 2022
  • Amara Therapeutics DTIF Funding Success 17 November 2022
  • Amara Therapeutics Runner-up Finalists in EIT Health Catapult 22 September 2022

Recent News

  • Privacy 02 October 2022
  • Amara Therapeutics Runner-up Finalists in EIT Health Catapult 22 September 2022
  • Cookie Policy 22 November 2022
  • Amara Therapeutics DTIF Funding Success 17 November 2022
  • Amara features in Enterprise Ireland Big Ideas Event 22 September 2022
© 2023 Amara Therapeutics Ltd., All Rights Reserved
  • Privacy Policy
  • Cookies Policy
  • Home
  • About
  • News
  • Pipeline
    • Overactive Bladder
    • Stress Urinary Incontinence
    • Pelvic Organ Prolapse
    • Interstitial Cystitis
    • Sexual Dysfunction
  • Careers
  • Contact